Vontobel Holding’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $38.4K | Sell |
34,000
-151,646
| -82% | -$171K | ﹤0.01% | 1094 |
|
2025
Q1 | $271K | Sell |
185,646
-9,811
| -5% | -$14.3K | ﹤0.01% | 925 |
|
2024
Q4 | $416K | Buy |
195,457
+173,457
| +788% | +$369K | ﹤0.01% | 840 |
|
2024
Q3 | $61.6K | Hold |
22,000
| – | – | ﹤0.01% | 1053 |
|
2024
Q2 | $51.3K | Buy |
22,000
+4,000
| +22% | +$9.32K | ﹤0.01% | 1040 |
|
2024
Q1 | $80.5K | Hold |
18,000
| – | – | ﹤0.01% | 1035 |
|
2023
Q4 | $57.8K | Buy |
18,000
+4,000
| +29% | +$12.8K | ﹤0.01% | 1065 |
|
2023
Q3 | $44.4K | Hold |
14,000
| – | – | ﹤0.01% | 1045 |
|
2023
Q2 | $69.6K | Sell |
14,000
-10,000
| -42% | -$49.7K | ﹤0.01% | 1063 |
|
2023
Q1 | $119K | Hold |
24,000
| – | – | ﹤0.01% | 1018 |
|
2022
Q4 | $151K | Sell |
24,000
-89,711
| -79% | -$564K | ﹤0.01% | 1014 |
|
2022
Q3 | $1.23M | Buy |
113,711
+4,067
| +4% | +$43.9K | 0.01% | 502 |
|
2022
Q2 | $1.25M | Buy |
+109,644
| New | +$1.25M | 0.01% | 490 |
|